Discover the involvement of Novartis in COVID-19 related research and collaborations.
Jennifer Leeds offers a behind-the-scenes look at the consortia forming to address COVID-19.
Novartis has joined the accelerator, coordinated by the Bill & Melinda Gates Foundation, Wellcome and Mastercard.
Novartis is supporting Conquer Cancer, the ASCO Foundation to allow for better understanding of COVID-19 in cancer care.
Novartis joins the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative.
Novartis is part of a consortium engaging with the Innovative Medicines Initiative (IMI) on their COVID-19 directed efforts.
Novartis is making available several compounds from our libraries that are considered suitable for in vitro antiviral testing.
This site is intended for a global audience.